Patient Care

Survivorship: Evaluating needs and the integrated model


 

Who is a survivor? Am I a survivor? Are you a survivor? What does a survivor need? How can community oncologists help? These are among the many questions a community oncologist can expect to hear during the course of treating a cancer patient, from the diagnosis, through the decisions about therapy, at all stages of treatment, and well into aftercare and follow-up. A “patient” used to be someone in active treatment, and a “survivor” was someone who had been free of disease for 5 years. More recently, Ellen Stoval of the National Coalition for Cancer Survivorship noted that the term “cancer survivor” can be used “to describe anyone who has been diagnosed with cancer as well as caregivers and loved ones of those diagnosed with the disease.”1 Her broader perspective more accurately captures the multifaceted nature of survivorship...

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Heparin Bridging Associated With Increased Bleeding Risk
MDedge Hematology and Oncology
IGF-I Doesn't Predict Late Complications in Childhood Cancer Survivors
MDedge Hematology and Oncology
Prostate Cancer Deaths: Annual Screen Not Superior to Usual Care
MDedge Hematology and Oncology
REVIEW: Comprehensive Management of Respiratory Symptoms in Patients with Advanced Lung Cancer
MDedge Hematology and Oncology
PEER VIEWPOINT: Targeting the Symptoms of Lung Cancer, Not Just the Disease
MDedge Hematology and Oncology
PEER VIEWPOINT: Respiratory Symptoms in Advanced Lung Cancer: A Persistent Challenge
MDedge Hematology and Oncology
Managing Side Effects of Tyrosine Kinase Inhibitor Therapy to Optimize Adherence in Patients with Chronic Myeloid Leukemia: The Role of the Midlevel Practitioner
MDedge Hematology and Oncology
Determinants of Physical Activity in Palliative Cancer Patients: An Application of the Theory of Planned Behavior
MDedge Hematology and Oncology
The impact of myelodysplastic syndromes on quality of life: lessons learned from 70 voices
MDedge Hematology and Oncology
Feds Bar Generic Drug Maker Ranbaxy
MDedge Hematology and Oncology